| Mr Gary Allen Zelazny, MD | |
|
3705 Medical Parkway, Suite 455, Austin, TX 78705 | |
| (512) 454-9646 | |
| (512) 323-6331 |
| Full Name | Mr Gary Allen Zelazny |
|---|---|
| Gender | Male |
| Speciality | Dermatology - Procedural Dermatology |
| Location | 3705 Medical Parkway, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578530663 | NPI | - | NPPES |
| P000P2507 | Medicaid | TX |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gary Allen Zelazny, MD 3705 Medical Parkway, Suite 455, Austin, TX 78705 Ph: (512) 454-9646 | Mr Gary Allen Zelazny, MD 3705 Medical Parkway, Suite 455, Austin, TX 78705 Ph: (512) 454-9646 |
News Archive
Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).
ClaimTrust®, a leading provider of revenue cycle tools and services for hospitals, today announced its new Recovery Audit Contractor Resource Center, which will provide hospitals with useful resources, information and tips that will help them prepare staff and infrastructure for RAC record requests, demand letters and appeals.
The END7 campaign, a global advocacy campaign run by the Global Network for Neglected Tropical Diseases (NTDs) "to raise awareness of the seven most common NTDs and cultivate the resources necessary to end them by 2020," is launching a tweet chat series on Twitter, which aims to bring global health non-governmental organizations together "to ask questions and share tips on social media," a post in the Global Network's "End the Neglect" blog reports.
Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).
› Verified 7 days ago
Dr. John Joseph Ghidoni Iii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8229 Shoal Creek Blvd, Suite#101, Austin, TX 78757 Phone: 512-371-7400 Fax: 512-371-7488 | |
Moise Levy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 200, Austin, TX 78723 Phone: 512-628-1920 Fax: 512-628-1921 | |
Dr. Susan Elizabeth Dozier, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8240 N Mo Pac Expwy, Suite 355, Austin, TX 78759 Phone: 512-527-9020 Fax: 512-527-9000 | |
Dr. Gregory A. Nikolaidis, Dermatology Medicare: Medicare Enrolled Practice Location: 8825 Bee Cave Rd, Suite 100, Austin, TX 78746 Phone: 512-328-3376 Fax: 512-399-6895 | |
Amy Ayres Mcclung, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9701 Brodie Ln Ste 106, Austin, TX 78748 Phone: 512-280-3939 Fax: 512-280-3938 | |
Stanley Tyler Hollmig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1601 Trinity St Ste 704b, Austin, TX 78712 Phone: 512-324-7468 Fax: 512-324-7469 | |
Dr. Lauren Piilani Rimoin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8825 Bee Caves Rd Ste 100, Austin, TX 78746 Phone: 512-328-3376 Fax: 512-666-3767 |